BioAge Labs, Valuation
| BIOA Stock | 19.70 0.63 3.30% |
At this time, the firm appears to be overvalued. BioAge Labs, shows a prevailing Real Value of 17.59 per share. The current price of the firm is 19.7. Our model approximates the value of BioAge Labs, from analyzing the firm fundamentals such as Number Of Shares Shorted of 2.21 M, shares owned by insiders of 3.80 %, and Current Valuation of 539.05 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BioAge Labs,'s valuation include:
Enterprise Value 539 M |
Overvalued
Today
Please note that BioAge Labs,'s price fluctuation is somewhat reliable at this time. Calculation of the real value of BioAge Labs, is based on 3 months time horizon. Increasing BioAge Labs,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BioAge Labs, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioAge Stock. However, BioAge Labs,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.7 | Real 17.59 | Hype 20.11 | Naive 20.63 |
The real value of BioAge Stock, also known as its intrinsic value, is the underlying worth of BioAge Labs, Company, which is reflected in its stock price. It is based on BioAge Labs,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioAge Labs,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioAge Labs, helps investors to forecast how BioAge stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioAge Labs, more accurately as focusing exclusively on BioAge Labs,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use BioAge Labs,'s intrinsic value based on its ongoing forecasts of BioAge Labs,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against BioAge Labs,'s closest peers. If more than one evaluation category is relevant for BioAge Labs, we suggest using both methods to arrive at a better estimate.
BioAge Labs, Cash |
|
BioAge Valuation Trend
Comparing BioAge Labs,'s enterprise value against its market capitalization is a good way to estimate the value of BioAge Labs, uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
BioAge Labs, Total Value Analysis
BioAge Labs, is currently estimated to have valuation of 539.05 M with market capitalization of 674.12 M, debt of 53.25 M, and cash on hands of 4.63 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioAge Labs, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
539.05 M | 674.12 M | 53.25 M | 4.63 M |
BioAge Labs, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of BioAge suggests not a very effective usage of assets in November.BioAge Labs, Ownership Allocation
BioAge Labs, holds a total of 34.17 Million outstanding shares. 30% of BioAge Labs, outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioAge Labs, Profitability Analysis
Net Loss for the year was (63.85 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioAge Labs,'s worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioAge Labs, and how it compares across the competition.
About BioAge Labs, Valuation
The stock valuation mechanism determines BioAge Labs,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of BioAge Labs,. We calculate exposure to BioAge Labs,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioAge Labs,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -6.6 M | -6.3 M | |
| Pretax Profit Margin | (6.15) | (6.46) | |
| Operating Profit Margin | (6.63) | (6.96) | |
| Net Loss | (5.91) | (6.21) | |
| Gross Profit Margin | (0.44) | (0.47) |
BioAge Labs, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 33.7 M |
BioAge Labs, Current Valuation Indicators
Valuation refers to the process of determining the present value of BioAge Labs, and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value BioAge we look at many different elements of the entity such as BioAge's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as BioAge Labs,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use BioAge Labs,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes BioAge Labs,'s worth.Complementary Tools for BioAge Stock analysis
When running BioAge Labs,'s price analysis, check to measure BioAge Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs, is operating at the current time. Most of BioAge Labs,'s value examination focuses on studying past and present price action to predict the probability of BioAge Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs,'s price. Additionally, you may evaluate how the addition of BioAge Labs, to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |